Why this longevity startup raised in Japan, not Silicon Valley | TWiST Tokyo | E2315

20 insights saved from this video by @business

@business· Startups
In this legal framework, people with incurable diseases can seek unapproved cell or gene therapies that might save their lives.
@business· Startups
Some blue-zone longevity findings were undermined when investigators found reported centenarians dead and relatives collecting their pensions.
@business· Startups
Japan tightened IPO standards after too many low-quality zombie companies reached the stock market, pushing startups toward M&A exits.
@business· Startups
Two biological-age tests can disagree because blood markers, sleep patterns, and stress measure different aspects of physiology.
@business· Startups
In biological AI, missing or mismatched data can matter more than sophisticated modeling.
@business· Startups
A practical AI-biology workflow generates purpose-built data first, then applies simple models to discovery and manufacturing.
@business· Startups
Aging therapies need infrastructure that measures aging before their effects can be clinically validated.
@business· Startups
Great companies are bought, not sold. Strong demand creates multiple offers. Chasing buyers tends to lower the price.
@business· Startups
Long-term platform value can justify sacrificing short-term revenue if better methods eventually produce cheaper, superior clinical products.
@business· Startups
Startup intensity belongs in a difficult sprint, not forever. Sustainable founders build rest into the marathon.
@business· Startups
Founders with families can protect ambition and family: work at 5 or 6 a.m., focus by day, have dinner, then work briefly at night.
@business· Startups
Cell-therapy quality control asks three questions: Is the batch potent, authentic, and consistent with the next batch?
@business· Startups
A founder seeking a quick sale may conflict with investors whose fund depends on a rare, outsized return.
@business· Startups
Protecting health and sleep means cutting low-value entertainment, not treating rest as expendable.
@business· Startups
Efficiency beats hours. Efficiency combined with sustained effort beats everything.
@business· Startups
Aging researchers track methylation changes across cohorts numbering hundreds or thousands of participants.
@business· Startups
AK Labs reads DNA-methylation signals at high resolution and low cost across different biological sample types.
@business· Startups
US venture funds can back capable international teams at lower valuations and test whether they can still reach large exits.
@business· Startups
Hiring machine-learning talent can help a still-manual organization use AI to accelerate its work.
@business· Startups
AK Labs generates high-resolution, low-cost epigenetic data for drug development, aging discovery, and cell-therapy manufacturing.

More from This Week in Startups

See everything from This Week in Startups

Post on X

Keep what you found in Why this longevity startup raised in Japan, not Silicon Vall…

A free account saves any of these cards to your Collection, and Korva resurfaces them so you actually remember.